Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2026-04-14 @ 3:11 AM
Study NCT ID:
NCT05245760
Status:
WITHDRAWN
Last Update Posted:
2022-11-08
First Post:
2022-02-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ChemoRadiation And Tislelizumab for Esophageal/EGJ Cancer
Sponsor:
Zhonglin Hao
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MCC-21-LUN-125-PMC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None